Active, not recruitingPhase 3NCT06910358
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
Studying Disorder of porphyrin and heme metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Disc Medicine, Inc
- Principal Investigator
- Will Savage, MD, PhDDisc Medicine
- Intervention
- Placebo(drug)
- Enrollment
- 183 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2025 – 2026
Study locations (28)
- Marvel Clinical Research, Huntington Beach, California, United States
- University of California San Francisco, San Francisco, California, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- MetroBoston Clinical Partners, Boston, Massachusetts, United States
- Henry Ford Health System, Detroit, Michigan, United States
- Mount Sinai Hospital, New York, New York, United States
- Wake Forest University, Winston-Salem, North Carolina, United States
- Remington-Davis Clinical Research, Columbus, Ohio, United States
- University of Texas Medical Branch, Galveston, Texas, United States
- University of Washington, Seattle, Washington, United States
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
- The Royal Melbourne Hospital, Parkville, Victoria, Australia
- UZ Leuven, Leuven, Belgium
- University of Alberta, Edmonton, Alberta, Canada
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06910358 on ClinicalTrials.govOther trials for Disorder of porphyrin and heme metabolism
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT06971900GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic ProtoporphyriaPortal Therapeutics, Inc.
- ACTIVE NOT RECRUITINGNCT02935400Acute Porphyria Biomarkers for Disease ActivityThe University of Texas Medical Branch, Galveston
- ACTIVE NOT RECRUITINGNCT01617642Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)Nordlandssykehuset HF
See all trials for Disorder of porphyrin and heme metabolism →